| ADT | androgen deprivation therapy |
| AR | androgen receptor |
| AREG | amphiregulin |
| BPH | benign prostatic hyperplasia |
| BIC | bicalutamide |
| CGS | celecoxib-controlled gene set |
| COX-2 | cyclooxygenase-2 |
| CRPC | castration-resistant prostate cancer |
| DHT | 5-α-dihydrotestosterone |
| DSigDB | Drug Signature Database |
| EGF | epidermal growth factor |
| EGFR-Erb | epidermal growth factor receptor |
| GO-BP | gene ontology-biological process |
| GSK3β | glycogen synthase 3β |
| H&E | hematoxylin and eosin |
| hnRNP K | heterogeneous nuclear ribonucleoprotein K |
| mHSPC | metastatic hormone-sensitive PCa |
| NSAIDs | non-steroidal anti-inflammatory drugs |
| PARP-1 | poly (ADP-ribose) polymerase-1 |
| PCa | prostate cancer |
| P38 | p38MAPK |
| PPI | protein–protein interaction |